Allogene Therapeutics, Inc. short interest in 2023
In 2023, Allogene Therapeutics, Inc.'s disclosed short interest ran from 23.69% of shares outstanding on 13 Jan 2023 to 18.61% on 29 Dec 2023, a change of -5.08 percentage points. The year's high was 28.59% on 14 Apr 2023 and its low 18.33% on 13 Oct 2023, averaging 23.44% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 29.10 days on 15 Feb 2023. Full history: Allogene Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 23.69% (13 Jan 2023)
- End of year
- 18.61% (29 Dec 2023)
- Change
- -5.08 pp
- High
- 28.59% (14 Apr 2023)
- Low
- 18.33% (13 Oct 2023)
- Average
- 23.44%
- Highest days to cover
- 29.10 (15 Feb 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 23.69% | 15.87 | |
| 31 Jan 2023 | 23.86% | 17.61 | |
| 15 Feb 2023 | 24.37% | 29.10 | |
| 28 Feb 2023 | 25.56% | 20.38 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 27.60% | 15.59 | |
| 31 Mar 2023 | 28.44% | 25.73 | |
| 14 Apr 2023 | 28.59% | 25.46 | |
| 28 Apr 2023 | 28.19% | 17.75 | |
| 15 May 2023 | 27.83% | 16.12 | 10-Q filed, results (8-K) |
| 31 May 2023 | 27.45% | 23.11 | |
| 15 Jun 2023 | 25.75% | 16.85 | |
| 30 Jun 2023 | 26.18% | 6.58 | |
| 14 Jul 2023 | 28.29% | 19.79 | |
| 31 Jul 2023 | 22.62% | 24.11 | |
| 15 Aug 2023 | 19.55% | 12.09 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 19.15% | 24.08 | |
| 15 Sep 2023 | 19.93% | 15.95 | |
| 29 Sep 2023 | 20.36% | 23.55 | |
| 13 Oct 2023 | 18.33% | 23.48 | |
| 31 Oct 2023 | 20.22% | 27.90 | |
| 15 Nov 2023 | 19.22% | 12.47 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 18.93% | 14.09 | |
| 15 Dec 2023 | 19.94% | 8.34 | |
| 29 Dec 2023 | 18.61% | 11.19 |
See also: Allogene Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.